{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T07:19:05Z","timestamp":1773213545226,"version":"3.50.1"},"reference-count":34,"publisher":"Wiley","issue":"6","license":[{"start":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T00:00:00Z","timestamp":1626393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":["onlinelibrary.wiley.com"],"crossmark-restriction":true},"short-container-title":["Int J Lab Hematology"],"published-print":{"date-parts":[[2021,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Objective<\/jats:title><jats:p>Somatic mutations in isocitrate dehydrogenase 1 and 2 (IDH1 and IDH2) frequently emerge in acute myeloid leukemia (AML), but the clinical features and molecular characteristics of IDH mutational status and other coexisting mutations have not been investigated in a large extensively characterized AML series. The aim of this study was to gain insight into the mutational profile of IDH\u2010mutated patients, such as the frequency and clinical characteristics of coexisting mutated genes.<\/jats:p><\/jats:sec><jats:sec><jats:title>Materials and Methods<\/jats:title><jats:p>We investigated 485 newly diagnosed AML patients (range 18\u201081\u00a0years). DNA was extracted from bone marrow samples at the time of diagnosis. All samples were investigated with a panel of 49 mutational genes using next\u2010generation sequencing (NGS). FLT3\u2010ITD, NPM1, and CEBPA mutations were detected by Sanger PCR sequencing.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>We found 84 patients (17.3%) with IDH1 or IDH2 mutations. There were 40 IDH1<jats:sup>R132<\/jats:sup>, 15 IDH2<jats:sup>R140Q<\/jats:sup>, 17 IDH2<jats:sup>R172K<\/jats:sup>, and 12 uncommon mutations. No patient was found to have both IDH1 and IDH2 mutations. Patients with IDH2<jats:sup>R140Q<\/jats:sup> mutations were more frequently older and presented with significantly lower average platelet counts, while IDH2<jats:sup>R172K<\/jats:sup>\u2010mutated patients had significantly lower white blood cell (WBC) counts. On the background of IDH mutations, the presence of a normal karyotype showed a balanced distribution. The four most frequently coexisting mutated genes were NPM1, DNMT3A, TET2, and FLT3\u2010ITD. The majority of coexisting mutated genes were involved in regulating transcription and DNA methylation. IDH mutation status had no effect on the CR rate, regardless of other molecular abnormalities.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusion<\/jats:title><jats:p>Isocitrate dehydrogenases mutations are associated with a complex coexisting mutation cluster in AML. Future investigation is needed to reveal the association between IDH mutations and other genetic abnormalities, which may have an impact on the progression and prognosis of disease.<\/jats:p><\/jats:sec>","DOI":"10.1111\/ijlh.13648","type":"journal-article","created":{"date-parts":[[2021,7,16]],"date-time":"2021-07-16T16:08:50Z","timestamp":1626451730000},"page":"1483-1490","update-policy":"https:\/\/doi.org\/10.1002\/crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Additional mutations in IDH1\/2\u2010mutated patients with acute myeloid leukemia"],"prefix":"10.1111","volume":"43","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6850-0763","authenticated-orcid":false,"given":"Jingtao","family":"Lu","sequence":"first","affiliation":[{"name":"Department of Hematology Affiliated Changzhou Second Hospital of Nanjing Medical University  Changzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meiyu","family":"Chen","sequence":"additional","affiliation":[{"name":"Department of Hematology Affiliated Changzhou Second Hospital of Nanjing Medical University  Changzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haiying","family":"Hua","sequence":"additional","affiliation":[{"name":"Department of Hematology The Affiliated Hospital of Jiangnan University  Wuxi China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Qin","sequence":"additional","affiliation":[{"name":"Department of Hematology Affiliated Changzhou Second Hospital of Nanjing Medical University  Changzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ri","family":"Zhang","sequence":"additional","affiliation":[{"name":"Department of Hematology The First Affiliated Hospital of Suzhou University Jiangsu Institute of Hematology Key Laboratory of Thrombosis and Hemostasis of Ministry of Health  Suzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuzhang","family":"Lu","sequence":"additional","affiliation":[{"name":"Department of Hematology Affiliated Changzhou Second Hospital of Nanjing Medical University  Changzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3836-9260","authenticated-orcid":false,"given":"Hongying","family":"Chao","sequence":"additional","affiliation":[{"name":"Department of Hematology Affiliated Changzhou Second Hospital of Nanjing Medical University  Changzhou China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2021,7,16]]},"reference":[{"key":"e_1_2_10_2_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.3762"},{"key":"e_1_2_10_3_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature11323"},{"key":"e_1_2_10_4_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa1516192"},{"key":"e_1_2_10_5_1","doi-asserted-by":"publisher","DOI":"10.1158\/0008-5472.CAN-14-2200"},{"key":"e_1_2_10_6_1","doi-asserted-by":"publisher","DOI":"10.1038\/srep16238"},{"key":"e_1_2_10_7_1","doi-asserted-by":"publisher","DOI":"10.1126\/science.1164382"},{"key":"e_1_2_10_8_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0903840"},{"key":"e_1_2_10_9_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.01.020"},{"key":"e_1_2_10_10_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature10860"},{"key":"e_1_2_10_11_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa0808710"},{"key":"e_1_2_10_12_1","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12271"},{"key":"e_1_2_10_13_1","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.31729"},{"key":"e_1_2_10_14_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2010-12-322479"},{"key":"e_1_2_10_15_1","first-page":"3074","article-title":"Prognostic implication of FLT3 and N\u2010RAS gene mutations in acute myeloid leukemia","volume":"93","author":"Kiyoi H","year":"1999","journal-title":"Blood"},{"key":"e_1_2_10_16_1","doi-asserted-by":"publisher","DOI":"10.1002\/hon.904"},{"key":"e_1_2_10_17_1","doi-asserted-by":"publisher","DOI":"10.1158\/1078-0432.CCR-04-1816"},{"key":"e_1_2_10_18_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.124"},{"key":"e_1_2_10_19_1","doi-asserted-by":"publisher","DOI":"10.1053\/shem.2002.36921"},{"key":"e_1_2_10_20_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.30.2554"},{"key":"e_1_2_10_21_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature13038"},{"key":"e_1_2_10_22_1","doi-asserted-by":"publisher","DOI":"10.2147\/CMAR.S157632"},{"key":"e_1_2_10_23_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.ccr.2010.11.015"},{"key":"e_1_2_10_24_1","doi-asserted-by":"publisher","DOI":"10.1002\/ajh.24072"},{"key":"e_1_2_10_25_1","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.2010.28.2285"},{"key":"e_1_2_10_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2017.244"},{"key":"e_1_2_10_27_1","doi-asserted-by":"publisher","DOI":"10.1101\/gad.226613.113"},{"key":"e_1_2_10_28_1","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMc0910063"},{"key":"e_1_2_10_29_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2010.98"},{"key":"e_1_2_10_30_1","doi-asserted-by":"publisher","DOI":"10.3324\/haematol.2018.191148"},{"key":"e_1_2_10_31_1","doi-asserted-by":"publisher","DOI":"10.1080\/16078454.2020.1765561"},{"key":"e_1_2_10_32_1","doi-asserted-by":"publisher","DOI":"10.1111\/ijlh.13030"},{"key":"e_1_2_10_33_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2015.129"},{"key":"e_1_2_10_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/leu.2014.243"},{"key":"e_1_2_10_35_1","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2017-04-779447"}],"container-title":["International Journal of Laboratory Hematology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.13648","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/full-xml\/10.1111\/ijlh.13648","content-type":"application\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/ijlh.13648","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,8,28]],"date-time":"2023-08-28T08:54:53Z","timestamp":1693212893000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/ijlh.13648"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,7,16]]},"references-count":34,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["10.1111\/ijlh.13648"],"URL":"https:\/\/doi.org\/10.1111\/ijlh.13648","archive":["Portico"],"relation":{},"ISSN":["1751-5521","1751-553X"],"issn-type":[{"value":"1751-5521","type":"print"},{"value":"1751-553X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,7,16]]},"assertion":[{"value":"2021-01-04","order":0,"name":"received","label":"Received","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-06-09","order":1,"name":"accepted","label":"Accepted","group":{"name":"publication_history","label":"Publication History"}},{"value":"2021-07-16","order":2,"name":"published","label":"Published","group":{"name":"publication_history","label":"Publication History"}}]}}